Supplement Manufacturing Glossary

Active Ingredient noun

A dietary ingredient present in a supplement that is intended to provide a physiological effect — the substance(s) responsible for the claimed benefit. Distinct from excipients or other inactive ingredients. In capsule supplements, the active ingredients are listed in the Supplement Facts panel with their amounts per serving.

Adulteration noun

The fraudulent substitution or addition of ingredients in a product — for example, replacing an expensive botanical with a cheaper species, or adding an undisclosed pharmaceutical compound to boost apparent efficacy. A significant problem in the supplement industry, particularly in weight-loss, sexual enhancement, and sports performance categories. Identity testing is the primary defense against adulteration.

Batch Production Record (BPR) document

A comprehensive manufacturing document created for each specific production lot. The BPR records every ingredient used (with supplier lot numbers and COAs), all equipment involved, in-process test results, finished product test results, and the QA manager's release authorization. Required by FDA 21 CFR Part 111. The BPR is the foundation of lot traceability — in the event of a recall, it enables identification of all affected finished product within hours. See also: Lot Number, Master Manufacturing Record.

Bioavailability noun

The proportion of an ingested substance that actually enters the systemic circulation and is available to exert its intended effect. Bioavailability is influenced by the dosage form (capsule, tablet, liquid), particle size of actives, presence of absorption enhancers or inhibitors, and individual physiological factors. A high-potency ingredient with poor bioavailability may deliver less active compound than a lower-potency ingredient with superior bioavailability. Formulators consider bioavailability when selecting ingredient forms (e.g., magnesium glycinate vs. magnesium oxide).

Blend Homogeneity noun

The uniformity of ingredient distribution throughout a blended powder mixture. A homogeneous blend contains consistent concentrations of all ingredients throughout the bulk — no "hot spots" with excessive active ingredient and no "cold spots" with insufficient. Blend homogeneity testing is performed on samples taken from multiple locations within the blend before encapsulation. Failure to achieve homogeneity results in dose variation between capsules.

Bulk Density noun

The mass per unit volume of a powder as it is handled in manufacturing — expressed as grams per milliliter (g/mL) or grams per cubic centimeter. Bulk density determines how much powder fits in a given capsule size. Fine, fluffy powders have low bulk density (more volume per gram); dense granules or mineral salts have high bulk density (less volume per gram). Manufacturers measure bulk density to calculate fill weights and select appropriate capsule sizes for a given formula.

Certificate of Analysis (COA) document

A quality assurance document accompanying a lot of material — either a raw ingredient or a finished product — that confirms the material has been tested and meets specified criteria. A raw material COA lists identity, potency, and contaminant test results. A finished product COA documents fill weight uniformity, potency confirmation, and QA release authorization. Under cGMP, manufacturers must review and verify supplier COAs against their own specifications before accepting raw materials. NSI provides a COA with every finished lot shipped.

cGMP (Current Good Manufacturing Practice) regulation

The FDA's manufacturing quality standard for dietary supplements, codified in Title 21 of the Code of Federal Regulations, Part 111 (21 CFR Part 111). cGMP establishes requirements for personnel training, facility design, equipment calibration, ingredient testing, master manufacturing records, batch production records, quality control testing, finished product specifications, complaint handling, and record retention. The "current" in cGMP signals that the standard evolves with advances in manufacturing technology — compliance means meeting current best practices, not just historical minimums. See: NSI Certifications.

Chelation noun

The chemical bonding of a mineral to an organic molecule (the chelating agent) to form a chelate. Chelated minerals — such as magnesium glycinate, zinc bisglycinate, and iron bisglycinate — typically exhibit improved absorption compared to inorganic mineral salts (e.g., magnesium oxide), because the chelating molecule facilitates transport across the intestinal wall. Chelated forms generally cost more than their inorganic equivalents; the formulation decision involves balancing cost and bioavailability for the target application.

Contract Manufacturing noun

An arrangement in which a brand owner provides a proprietary formula to a manufacturer (the contract manufacturer) who produces the product to the brand's specification. The brand owns the formula; the manufacturer provides production, testing, and packaging services. Distinct from Private Label, where the brand uses the manufacturer's existing formula rather than a proprietary one. Contract manufacturing offers complete control over ingredients and ratios; the manufacturer must maintain confidentiality of the formula.

Controlled Room Temperature (CRT) noun

A storage condition defined by the USP as 68°F–77°F (20°C–25°C), with permitted brief excursions between 59°F and 86°F (15°C and 30°C). Most dietary supplements carry the label instruction "Store in a cool, dry place" or "Store at controlled room temperature." Temperatures above CRT can accelerate degradation of active ingredients and soften gelatin capsule shells.

Desiccant noun

A hygroscopic material — typically silica gel or molecular sieve — placed inside a supplement bottle to absorb ambient moisture and maintain a low-humidity headspace. Desiccants protect moisture-sensitive capsule shells, prevent powder clumping, and extend shelf life for hygroscopic active ingredients. Available in canisters (for inclusion as a separate component inside the bottle) or sachets (packets). The type and quantity of desiccant required depends on the moisture sensitivity of the formula and the moisture-barrier properties of the container.

Dissolution noun

The process by which a solid dosage form (capsule shell and fill) disintegrates and its contents dissolve in gastric fluid, making the active ingredients available for absorption. Dissolution testing measures the rate and extent of this process under standardized in-vitro conditions (USP dissolution apparatus, defined medium, temperature, and stirring speed). Hard gelatin and HPMC capsules typically dissolve within 15 minutes under standard conditions. Delayed or incomplete dissolution reduces bioavailability.

Dosage Form noun

The physical form in which a supplement is consumed. Common dietary supplement dosage forms include: hard capsules (two-piece, dry-fill), softgel capsules (liquid-fill), tablets (compressed powder), powders (bulk or single-serve sachets), gummies (chewable gelatin or pectin-based), and liquids. The choice of dosage form affects consumer acceptance, manufacturing complexity, stability, and bioavailability of active ingredients.

Excipient noun

An inactive ingredient added to a supplement formula to serve a manufacturing or stability function, not for direct physiological effect. Common excipients in hard capsule supplements include magnesium stearate (lubricant), silicon dioxide (flow agent), and microcrystalline cellulose (filler/binder). All excipients must be disclosed on the supplement label under "Other Ingredients." cGMP requires that excipient levels be validated and documented. See: Magnesium Stearate, Silicon Dioxide, Microcrystalline Cellulose.

FDA 21 CFR Part 111 regulation

Title 21, Code of Federal Regulations, Part 111 — the FDA's Current Good Manufacturing Practice regulation for dietary supplements. Finalized in 2007, it establishes comprehensive manufacturing quality requirements for all dietary supplement manufacturers who market products in the United States. It covers personnel, facilities, equipment, production controls, laboratory operations, finished product testing, packaging, labeling, distribution, and complaint handling. Non-compliance can result in warning letters, import alerts, injunctions, or criminal prosecution. See: NSI Certifications.

Fill Weight noun

The mass of powder (or other fill material) contained inside a single capsule. Fill weight is determined by the capsule's internal volume and the bulk density of the fill material. It must match the target weight specified in the formula — if the serving size is 500 mg per capsule, the fill weight should be 500 mg. cGMP requires that fill weight variation across a lot be within a specified tolerance (typically ±3–5% per capsule) to ensure dose consistency. Fill weight is measured by weighing empty capsule shells before filling and filled capsules after filling.

Flow Agent noun

An excipient added to a powder blend to improve its flowability — its ability to move through production equipment hoppers, augers, and filling mechanisms consistently. Poor flowability causes bridging (powder arching over openings), rat-holing (empty channels forming), and erratic fill weight. Silicon dioxide (silica) is the most common flow agent in supplement manufacturing, used at 0.5–2% of blend weight. See: Silicon Dioxide.

GMP (Good Manufacturing Practice) regulation

A quality system framework that establishes minimum requirements for manufacturing processes, personnel, facilities, equipment, and documentation. GMP principles originate in pharmaceutical manufacturing but have been adapted for dietary supplements (see cGMP / 21 CFR Part 111), food production, cosmetics, and medical devices. "Current" GMP (cGMP) emphasizes that the standard is dynamic — manufacturers must implement current best practices rather than historical minimums.

Hard Capsule noun

A two-piece solid dosage form consisting of a cylindrical body (filled with dry powder, granules, or pellets) and a shorter cap that locks over the body. Also called two-piece capsule, hard shell capsule, or dry-fill capsule. Hard capsules are the most common supplement dosage form. The shell material is either gelatin (animal-derived) or HPMC (vegetarian). Available in standard sizes 000 (largest) through 4 (smallest). See: Hard Capsule Complete Guide.

Heavy Metals noun

A category of elemental contaminants — primarily lead (Pb), arsenic (As), cadmium (Cd), and mercury (Hg) — that may be present as trace contaminants in dietary supplement ingredients. Botanical raw materials can accumulate heavy metals from contaminated soils; mineral ingredients may carry metallic impurities from extraction. The FDA has established limits for heavy metals in dietary supplements; California's Proposition 65 adds additional threshold requirements. Heavy metals are typically quantified by ICP-MS at parts-per-billion levels.

HPMC (Hydroxypropyl Methylcellulose) noun

A plant-derived polymer made from cellulose and used to manufacture vegetarian capsule shells. HPMC capsules are suitable for vegan, vegetarian, halal, and kosher markets and are a direct substitute for gelatin capsules in terms of fill material compatibility and standard sizing. HPMC has lower equilibrium moisture content (3–7%) compared to gelatin (13–16%), which can be advantageous for moisture-sensitive active ingredients but requires attention to packaging to prevent over-drying and brittleness. HPMC capsules are available in the same size range (000–4) as gelatin capsules. See: Hard Capsule Guide.

Hygroscopic adjective

Describes a substance that readily absorbs and retains moisture from the surrounding atmosphere. Hygroscopic supplement ingredients include choline salts, certain amino acids, magnesium chloride, and some botanical spray-dried extracts. Hygroscopic actives can cause powder clumping during blending, capsule shell softening in finished product, and accelerated chemical degradation. Management strategies include desiccant packaging, encapsulation in HPMC capsules, and use of silicon dioxide flow agents. See: Desiccant.

Identity Testing noun

Analytical confirmation that an ingredient is what it is represented to be. Under 21 CFR Part 111, manufacturers must test the identity of every component used in production before it enters the manufacturing process. Identity testing methods range from organoleptic (appearance, odor, color comparison) to instrumental techniques such as TLC, HPLC, FTIR spectroscopy, or DNA-based methods. Identity testing is the primary defense against adulteration and ingredient substitution in the raw material supply chain.

Label Claim noun

The stated quantity of an active ingredient per serving as declared on the Supplement Facts panel of a dietary supplement label. Under cGMP, finished product testing must confirm that the actual content of each active ingredient meets the label claim within defined acceptance criteria. Products that contain significantly less than the label claim are misbranded under FDA regulations. "Overaging" (formulating with excess active to compensate for expected potency loss over shelf life) is used for ingredients susceptible to degradation.

Lot Number noun

A unique identifier assigned to a specific production batch, printed on each finished product container. The lot number links the finished product to its complete Batch Production Record, enabling traceability backward to every raw material used and forward to all customers who received product from that lot. Required by 21 CFR Part 111. In the event of a recall, lot numbers enable targeted retrieval of affected product rather than broad market withdrawals. See: Batch Production Record.

Magnesium Stearate noun

A salt of magnesium and stearic acid used as a lubricant in capsule and tablet manufacturing. Added at 0.25–1.0% of blend weight to prevent powder from adhering to capsule filling equipment and improve powder flow. Magnesium stearate is one of the most widely used excipients in the supplement and pharmaceutical industries. It is derived from vegetable or animal (beef tallow) sources — formulas targeting vegetarian markets should specify vegetable-source magnesium stearate. At standard use levels, it has no clinically meaningful effect on bioavailability of most active ingredients.

Master Manufacturing Record (MMR) document

A comprehensive written document for each distinct dietary supplement product that specifies the complete formula (all ingredients and amounts), specifications for each component, detailed manufacturing instructions, in-process controls, finished product specifications, and packaging/labeling instructions. Required by 21 CFR Part 111. The MMR is the master template from which Batch Production Records are derived — every batch must be produced according to the current approved MMR. Changes to formulas or processes require MMR revision and documentation.

Microcrystalline Cellulose (MCC) noun

A refined wood pulp derivative used as a filler, binder, and flow aid in dietary supplement manufacturing. In capsule formulations, MCC is most commonly used as a diluent — added when the volume of active ingredients is insufficient to fill the selected capsule size to the required fill weight range, allowing the manufacturer to use a larger capsule without switching to a smaller one. MCC contributes negligible caloric content and has an established safety profile. Appears on labels as "microcrystalline cellulose" under Other Ingredients.

Minimum Order Quantity (MOQ) noun

The smallest production run a manufacturer will accept for a given product. MOQs vary widely — large contract manufacturers may require 50,000–100,000 units; small-batch specialists like NSI work with significantly lower minimums appropriate for emerging brands. MOQ is determined by production economics: setup time, raw material procurement costs, and QA overhead are largely fixed regardless of batch size, so very small runs have high per-unit overhead costs. Brands should evaluate MOQs in the context of their launch strategy and working capital constraints.

NDI (New Dietary Ingredient) noun

A dietary ingredient not marketed in the United States before October 15, 1994 — the date DSHEA was enacted. Before marketing a product containing an NDI, manufacturers must submit an NDI notification to the FDA demonstrating that the ingredient is reasonably expected to be safe. The FDA has a list of ingredients considered "grandfathered" (in use before 1994); ingredients introduced after that date require NDI notification unless they meet a grandfather exemption. NDI status is a critical compliance consideration during product formulation.

NSF International organization

An independent non-profit organization providing testing, auditing, and certification services for dietary supplements, food safety, and other sectors. NSF's dietary supplement programs include the Certificate of Conformity (verifying a manufacturer's quality management system through facility audits) and NSF Certified for Sport (product testing for sport-prohibited substances). An NSF certificate is widely recognized by retailers, distributors, and regulatory agencies as credible evidence of quality system compliance. NSI holds an NSF Certificate of Conformity. Download it at our certifications page.

OEHHA (Office of Environmental Health Hazard Assessment) organization

The California state agency responsible for administering Proposition 65, formally the Safe Drinking Water and Toxic Enforcement Act of 1986. OEHHA maintains a list of chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm. Supplement products sold in California that contain listed chemicals above defined safe harbor levels must carry a Proposition 65 warning label. Heavy metals (particularly lead) are the most common trigger for Prop 65 warnings in dietary supplements.

Potency Testing noun

Analytical testing that quantifies the actual amount of an active ingredient present in a finished supplement, compared against the label claim. Potency testing is performed using instrumental analytical methods appropriate to each ingredient class — HPLC for most vitamins and botanical extracts, ICP-MS for minerals, GC for fatty acids, plate count for probiotics. Results are expressed as percentage of label claim; acceptable ranges are defined in the product specification. Potency testing at finished product release is required under 21 CFR Part 111. See also: Label Claim.

Private Label noun

A business arrangement in which a brand owner purchases a manufacturer's existing, pre-validated formula and sells it under their own brand name and label. The brand doesn't own the formula; the manufacturer produces it for multiple clients under different labels. Private label offers faster time to market and lower development costs compared to contract manufacturing of a proprietary formula, making it appropriate for brands testing new categories or entering the market with limited capital. Contrast with: Contract Manufacturing.

QA (Quality Assurance) noun

The systematic process of verifying that quality requirements are being met throughout the manufacturing process — from raw material qualification through finished product release. QA encompasses the entire quality management system: SOPs, training records, equipment calibration, in-process testing, finished product testing, batch record review, and lot release authorization. QA is both preventive (preventing quality failures from occurring) and detective (identifying quality failures before product ships). Distinct from QC, though the terms are often used interchangeably in common usage.

QC (Quality Control) noun

The testing and inspection activities performed to confirm that a specific lot or batch meets its specifications. QC activities include raw material identity testing, blend homogeneity checks, fill weight testing, potency analysis, and microbiological testing. QC generates the data that QA uses to make release decisions. While QA manages the overall quality system, QC executes the specific tests and measurements that demonstrate compliance for individual lots. See: QA.

Raw Material noun

Any ingredient, excipient, or packaging component received from a supplier and used in the manufacture of a dietary supplement. Under 21 CFR Part 111, all raw materials must be received into a quarantine area, have their identity tested before use, and be supported by a supplier's Certificate of Analysis that the manufacturer verifies against internal specifications. Raw materials that fail incoming testing must be rejected and cannot enter the manufacturing process.

Recall noun

The removal of a product from the market because it is adulterated, misbranded, or poses a safety risk. Dietary supplement recalls may be voluntary (initiated by the manufacturer or brand) or FDA-requested. An effective recall depends on complete lot traceability — knowing exactly which customers received product from each affected lot. Manufacturers with complete Batch Production Records and lot tracking can execute targeted recalls; those without adequate records may be forced to withdraw entire product lines.

Serving Size noun

The amount of a supplement product intended for a single use, declared on the Supplement Facts panel. For capsule products, serving size is expressed as a number of capsules (e.g., "1 capsule," "2 capsules"). The serving size determines the total amount of each active ingredient delivered per dose — if a formula contains 500 mg of an active per capsule and the serving size is 2 capsules, the label declares 1,000 mg per serving. Serving size is defined by the manufacturer based on formula design and intended use.

Silicon Dioxide noun

Also called silica or colloidal silicon dioxide. A flow agent added to powder blends at 0.5–2% by weight to improve flowability by reducing cohesive forces between fine powder particles. Silicon dioxide is odorless, tasteless, and chemically inert at supplement use levels. It is one of the most commonly used excipients in dietary supplement manufacturing. Appears on supplement labels as "silicon dioxide" or "silica" under Other Ingredients. See: Flow Agent.

Softgel noun

A single-piece, liquid-filled dosage form produced by encapsulating a liquid or semi-solid fill within a gelatin shell using a rotary die process. Softgels are used for fat-soluble vitamins (A, D, E, K), omega-3 fatty acids, coenzyme Q10, and other lipophilic actives. They offer excellent bioavailability for fat-soluble compounds but are not produced at NSI (our facility specializes in hard capsule/two-piece encapsulation). Distinct from hard capsules.

Specification noun

A documented set of criteria that a material or product must meet to be considered acceptable. Specifications for raw materials define identity, potency range, physical characteristics, and contaminant limits. Finished product specifications define acceptable ranges for fill weight, potency (% of label claim), dissolution, and microbiological limits. Every test result from QC testing is compared against the relevant specification; materials that fall outside specification must be rejected or placed on hold pending investigation. Specifications are documented in the Master Manufacturing Record.

Supplement Facts Panel noun

The mandatory nutrition labeling format for dietary supplements, required by FDA regulations (21 CFR Part 101.36). The Supplement Facts panel declares serving size, servings per container, each dietary ingredient with its amount per serving, percent Daily Value where established, and "Other Ingredients" (excipients). The panel is analogous to the Nutrition Facts panel on food products but specifically designed for dietary supplements. Incorrect or misleading Supplement Facts declarations constitute misbranding under FDA law.

Tare Weight noun

The weight of an empty container — a bottle, capsule shell, or packaging component — before the fill material is added. In capsule manufacturing, tare weight is the weight of the empty capsule shell; subtracting tare from the filled capsule weight gives the fill weight. Accurate tare measurement is essential for fill weight calculation and label claim accuracy. Under cGMP, weighing equipment must be calibrated and tare weights documented as part of in-process controls.

Third-Party Testing noun

Analytical testing performed by an independent laboratory — not the product manufacturer or brand — to verify quality, identity, potency, or purity claims. Third-party testing is used for: validating in-house analytical methods, testing categories requiring specialized instrumentation (full pesticide panels, comprehensive mycotoxin testing), and certifying products for specific claims (NSF Certified for Sport, Informed Sport). Third-party testing provides an independent verification layer but does not replace a manufacturer's internal QA program. See: NSF International.

USP (United States Pharmacopeia) organization

A non-profit scientific organization that establishes quality standards — specifications, testing methods, and reference standards — for drugs, dietary supplements, and food ingredients sold in the United States. USP publishes the United States Pharmacopeia-National Formulary (USP–NF), a compendium of quality standards widely referenced by supplement manufacturers and testing laboratories. The USP also operates a voluntary dietary supplement verification program, awarding the USP Verified mark to products that meet its standards for ingredient identity, potency, and contaminant limits through product testing.

Vegetarian Capsule noun

A capsule shell made from plant-derived materials rather than animal-derived gelatin. The most common vegetarian capsule material is HPMC (hydroxypropyl methylcellulose), though pullulan (a fermentation-derived polysaccharide) is also used. Vegetarian capsules are appropriate for consumers who avoid animal products on ethical, religious, or dietary grounds. They are certifiable as vegan, vegetarian, halal, and kosher. Available in the same size range as gelatin capsules. NSI stocks and fills both gelatin and HPMC vegetarian capsules. See: HPMC.

Weight Variation noun

A measure of the variability in fill weight across the capsules in a production lot. Weight variation testing — also called fill weight uniformity testing — involves weighing a statistically significant sample of filled capsules, subtracting shell tare weight, and calculating the distribution of fill weights across the sample. Acceptable limits are defined in the product specification, typically ±3–5% of the target fill weight. High weight variation indicates inconsistent capsule filling that can result in dose variation between capsules — a quality failure with direct consumer safety implications.